Excellence in Pharmacovigilance: Clinical trials and post-marketing

Jan 26, 2015

Excellence in Pharmacovigilance: Clinical trials and post-marketing

During the five-day training course Excellence in Pharmacovigilance: Clinical trials and post-marketing PharmInvent CEO Dr Jan Petracek will lecture on multiple topics including Signal Management in the European Union; challenges and possibilities of Risk Communication in EU; and an industry perspective on Risk Management Plans.

The DIA course held from February 9th through February 13th in London offers attendees the opportunity to gain a solid understanding of Clinical Pre- and Post-Marketing Safety regulatory requirements. The 5-day course will also explore the recent updates to pharmacovigilance legislation as well as address the current state of the global harmonisation and standardisation activities in pharmacovigilance.

This course has consistently received excellent reviews. Some comments from last year‘s course:

"Not really much to add, well-organized, focused and resourceful course conducted in a friendly environment with a lot of shared practical experience and opportunities to discuss individually - well done."

"Excellent course, very useful for my job."

For further details about the course, please visit: DIA webpage

Back to previous page...